Parkwalk portfolio company CCMOSS – acquired by ams AG to become world leader in gas and infrared sensing
ams AG (SIX: AMS), a leading worldwide manufacturer of high performance sensor and analog solutions, has acquired 100% of the shares in Cambridge CMOS Sensors Ltd (CCS), the technology leader in micro hotplate structures for gas sensing and… Read More
DefiniGEN – Parkwalk closes follow on investment
Parkwalk closes DefiniGen investment for the University of Cambridge Enterprise Fund IV and Parkwalk Funds DefiniGEN, a spin-out from the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital, have created a stem cell technology to provide human… Read More
Cambridge Touch Technologies – University of Cambridge Enterprise Fund III investment
We have recently made an investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund III in a seed financing round. Cambridge Touch Technologies (CTT), a University of Cambridge start-up poised to make 3D touch technology a standard… Read More
Sphere Fluidics – University of Cambridge Enterprise Fund III closes further funding round
We have closed an investment, in a $7m funding round, in Sphere Fluidics for the University of Cambridge Enterprise Fund III. This follows the UCEFs I and II investing previously. The investment round has been led by an Asian corporate investor Sphere Fluidics… Read More
Silicon Microgravity – University of Cambridge Enterprise Fund III investment
We have recently made an investment in Silicon Microgravity for the University of Cambridge Enterprise Fund III. Spun-out of the University of Cambridge Nanoscience Centre, Silicon Microgravity is commercializing a sensor technology which provides a breakthrough in the management… Read More
RoadMap – University of Cambridge Enterprise Fund III investment
We have recently made an investment in RoadMap for the University of Cambridge Enterprise Fund III in a Series ‘A’ financing. RoadMap is founded on four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics (CAPE) in… Read More
GeoSpock – Parkwalk closes investment
GeoSpock completes £3,500,000 ($5,400,000) Series A fundraising UK tech firm raises cash to commercialise its real-time database products for extreme-scale, rapidly-changing and complex data. Cambridge UK, October 6th 2015; GeoSpock Limited (GeoSpock) today announces the close of a… Read More
Cytora – Parkwalk closes Investment for the University of Cambridge Enterprise Fund III
We are pleased to announce that the University of Cambridge Enterprise Fund III has closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge. Cytora is a pioneer in event detection, whose risk analytics… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into Aqdot on behalf of the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III. Aqdot is a spin-out from the Department of Chemistry at the University of Cambridge and was… Read More
Parkwalk closes Quethera investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in Quethera, a gene therapy company spun-out of the University with a novel treatment for glaucoma. Quethera announces seed financing to develop… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III.. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors is a leading… Read More
Parkwalk closes Reduse investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in Reduse, a spin out from the Low Carbon Materials Processing Group at the University of Cambridge. Reduse are seeking to change… Read More
Oxbridge spin-out event
Parkwalk are delighted to have sponsored the first joint Oxford and Cambridge University spin-out investor event, which was held at the London Stock Exchange yesterday. Dame Carol Robinson, the first female professor of chemistry at both Oxford and Cambridge universities,… Read More
Horizon Discovery – Placing to raise approximately £25 million to accelerate the Company’s growth strategy
Horizon Discovery Group plc (LSE:HZD), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, is pleased to announce a conditional non-pre-emptive placing of 13,157,895 New Placing Shares… Read More
Parkwalk closes PhoreMost investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in PhoreMost as part of a £4m series ‘A’ round of equity and grant funding, of which the equity tranche was… Read More
Horizon Discovery – Positive Trading Update
Revenues expected to be ahead of consensus by approximately 7% driven by an increased global demand for expanded product, service and IP offering Cambridge, UK – 19th January 2014: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the… Read More
FT: Fluidic Analytics develops tools to warn of diseases
Imagine if a simple pinprick blood test could tell if you were in the early stages of Alzheimer’s or heart disease. This is the vision behind Fluidic Analytics, spun out of Cambridge university, which is developing tools to… Read More
Fluidic Analytics – University of Cambridge Enterprise Fund II and Parkwalk investment
Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund II and Parkwalk Funds. Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining… Read More
Horizon Discovery – acquires Sage Labs Inc. for $48M
Acquisition makes Horizon the world’s leading gene-editing and translational genomics company Highlights · Horizon acquires Sage Labs Inc. for up to $48M (£29M) comprising up to $16M in cash and up to $32M in new ordinary shares · Acquisition creates a… Read More
University of Cambridge Enterprise Fund IV launched
Parkwalk are delighted to announce the launch of the University of Cambridge Enterprise Fund IV. Launched in conjunction with Cambridge Enterprise, the University’s Technology Transfer and academic consulting subsidiary, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in… Read More
Posted on February 22, 2016
Fund Managers Comments
Cambridge, UoCEF IV